Volume 4 (Cancer Sensitizing Agents for Chemotherapy) 1st Edition
by Zhe-Sheng (Jason) Chen (Editor), Dong-Hua Yang (Editor)
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses
on strategic combination therapies that involve a variety of tyrosine
kinase inhibitors working together to overcome multi-drug resistance in
cancer cells. The book discusses several tyrosine kinase inhibitors that
have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and
BRAF. In each chapter, readers will find comprehensive knowledge on the
inhibitor and its action, including its biochemical, genetic, and
molecular mechanisms' emphases. This book is a valuable source for
oncologists, cancer researchers and those interested in applying new
sensitizing agents to their research in clinical practice and in trials.
- Summarizes the sensitizing role of some tyrosine kinase inhibitors in existing research
- Brings
recent findings in several cancer types, both experimental and
clinically, with a particular emphases on underlying biochemical,
genetic, and molecular mechanisms
- Provides an updated and comprehensive knowledge regarding the field of combinational cancer treatment
